Lyme does not only depress the immune system though it also employs endotoxins, biotoxins and neurotoxins that cause chronic inflammation which assists in the spread of cancer. In simple terms, when the immune system is compromised by Lyme and its co-infections, it can become increasingly more unlikely to rid the body of these naturally occurring cancer growths, making Lyme disease patients more susceptible to developing cancer. Normally, the immune system identifies these cancer cells and kills them before they reproduce spreading their mutated genes. A healthy immune system identifies and destroys a countless number of preliminary cancer cells every day cancer cell growth is a natural process that occurs when a cell's DNA begins to degrade. This leads to a highly compromised immune system that is now susceptible to opportunistic infections that intern further depress the immune system. After Lyme and the co-infections have a chance to propagate in the patient's body the immune system will start to become over taxed trying to fight off the multitude of infections and will even start to attack the body's own cells as the biotoxins and endotoxins confuse it. When a tick bites and passes Lyme disease, there is a high chance it is going to pass whatever viral, fungal, parasitic, and bacterial infections it has as well. Lyme Disease and Co-Infections Assist in Immune Suppression That May Lead to Cancer It is important to understand that Lyme disease is rarely seen alone and is almost always accompanied by other infections which must be addressed for proper treatment and cancer prevention. Lyme and its co-infections can severely depress the immune system making the body more susceptible to viral infections which can alter cellular DNA leading to cancer in a process known as oncogenesis. Lyme disease and it coinfections directly cause inflammation of muscle and nerve tissue through endotoxins, biotoxins, and neurotoxins released by the bacterial infection. Lyme disease patients may be very susceptible to cancer as Lyme can directly or indirectly cause all three of the mechanics that lead to tumor growth. Fortunately, Envita has developed patient specific and targeted treatment plans for Lyme disease and many of its coinfections, reducing the risk of developing cancer from infections for their patients. Infections have been shown to have three major modes of either causing or assisting in tumor growth, they cause inflammation, depress the immune system, and they can alter DNA causing mutations in the cell. Lyme disease is a complicated bacterial infection that is often seen accompanied by many other co-infections, this heightened number of infections could be making patients more susceptible to cancer. Prato remarks about Envita's experience investigating the link between infections and cancer, “When we first started testing our patients we couldn't believe that over 90% of late-stage cancer patients would have infection etiology connected to either causation and/or complication leading to cancer growth factors and/or immune impairment.” Lyme Disease's Role in Cancer Development Treatments used in this case may not all be FDA approved for the treatment of this condition. Not every patient is a candidate for care or achieves these results. Please consult your doctor before making any changes to your medical treatment. A surprisingly high number of Envita's patients with late-stage cancer test positive for Lyme disease as well as its primary or secondary coinfections.ĭisclaimer: Individual results will vary. Patients with chronic Lyme disease may not realize the potential cancer risk they are exposing themselves to. What you may not know is that recent data suggests 25% of all infections may potentially lead to cancer and this statistic, in our clinical experience, could be an underestimate. Data is very clear that specific cancers are linked to certain infections, many people are aware that infections like HPV can lead to cervical cancer, and Epstein Barr can cause Hodgkin's Lymphoma. This accumulation of clinical data has allowed Envita to notice a recurring trend between cancer patients and underlying chronic infections, leading to a published paper on the subject in the 2014 Open Journal of Medical Microbiology titled Cancer and Infectious Causes. Envita Medical Centers has been treating cancer for nearly two decades, in that time they have tested and reviewed thousands of patients and their potential causes of cancer.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |